Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Snowden Pencer Seeks Laparoscopy Partner Following Genzyme Spin-Off

This article was originally published in The Gray Sheet

Executive Summary

Snowden Pencer, Inc. is seeking a marketing and distribution partner for its line of laparoscopic instruments in the wake of a management-led buyout from Genzyme Biosurgery

You may also be interested in...



Cardiothoracic Sale Contemplated As Genzyme Ends Tracking Stock Strategy

Genzyme Biosurgery plans to divest the bulk of its cardiothoracic devices business by year-end to focus on its orthopedics and biosurgical specialties units

Cardiothoracic Sale Contemplated As Genzyme Ends Tracking Stock Strategy

Genzyme Biosurgery plans to divest the bulk of its cardiothoracic devices business by year-end to focus on its orthopedics and biosurgical specialties units

Genzyme Biosurgery Restructuring Emphasizes R&D Over Hardware

Genzyme Biosurgery intends to redirect a portion of its roughly $45 mil. annual R&D budget toward early stage studies of cell therapy for cardiac indications and potential uses of gene therapy during cardiac surgery.

Related Content

UsernamePublicRestriction

Register

MT015792

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel